ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis

FRA:EUZ • DE0005659700

15.42 EUR
+0.25 (+1.65%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

7

EUZ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EUZ a very profitable company, without any liquidiy or solvency issues. EUZ is growing strongly while it is still valued neutral. This is a good combination! This makes EUZ very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EUZ had positive earnings in the past year.
  • In the past year EUZ had a positive cash flow from operations.
  • In the past 5 years EUZ has always been profitable.
  • Each year in the past 5 years EUZ had a positive operating cash flow.
EUZ.DE Yearly Net Income VS EBIT VS OCF VS FCFEUZ.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.79%, EUZ belongs to the top of the industry, outperforming 87.69% of the companies in the same industry.
  • EUZ has a better Return On Equity (17.17%) than 90.77% of its industry peers.
  • EUZ's Return On Invested Capital of 12.48% is amongst the best of the industry. EUZ outperforms 89.23% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EUZ is in line with the industry average of 9.73%.
  • The last Return On Invested Capital (12.48%) for EUZ is above the 3 year average (9.92%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.79%
ROE 17.17%
ROIC 12.48%
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
EUZ.DE Yearly ROA, ROE, ROICEUZ.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of EUZ (13.06%) is better than 78.46% of its industry peers.
  • In the last couple of years the Profit Margin of EUZ has declined.
  • The Operating Margin of EUZ (21.27%) is better than 86.15% of its industry peers.
  • EUZ's Operating Margin has improved in the last couple of years.
  • The Gross Margin of EUZ (47.25%) is worse than 66.15% of its industry peers.
  • EUZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.27%
PM (TTM) 13.06%
GM 47.25%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
EUZ.DE Yearly Profit, Operating, Gross MarginsEUZ.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • EUZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • EUZ has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EUZ has more shares outstanding
  • EUZ has a better debt/assets ratio than last year.
EUZ.DE Yearly Shares OutstandingEUZ.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EUZ.DE Yearly Total Debt VS Total AssetsEUZ.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • EUZ has an Altman-Z score of 4.70. This indicates that EUZ is financially healthy and has little risk of bankruptcy at the moment.
  • EUZ has a better Altman-Z score (4.70) than 78.46% of its industry peers.
  • EUZ has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.05, EUZ belongs to the best of the industry, outperforming 86.15% of the companies in the same industry.
  • EUZ has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • EUZ has a better Debt to Equity ratio (0.16) than 73.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.05
Altman-Z 4.7
ROIC/WACC1.75
WACC7.12%
EUZ.DE Yearly LT Debt VS Equity VS FCFEUZ.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • EUZ has a Current Ratio of 2.93. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.93, EUZ is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • EUZ has a Quick Ratio of 2.37. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.37, EUZ belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.37
EUZ.DE Yearly Current Assets VS Current LiabilitesEUZ.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

7

3. Growth

3.1 Past

  • EUZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.67%, which is quite impressive.
  • EUZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.65% yearly.
  • Looking at the last year, EUZ shows a quite strong growth in Revenue. The Revenue has grown by 9.64% in the last year.
  • The Revenue has been growing by 10.63% on average over the past years. This is quite good.
EPS 1Y (TTM)43.67%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%68.5%
Revenue 1Y (TTM)9.64%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%7.42%

3.2 Future

  • EUZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.41% yearly.
  • Based on estimates for the next years, EUZ will show a quite strong growth in Revenue. The Revenue will grow by 8.10% on average per year.
EPS Next Y52.31%
EPS Next 2Y16.15%
EPS Next 3Y16.41%
EPS Next 5YN/A
Revenue Next Year7.52%
Revenue Next 2Y7.63%
Revenue Next 3Y8.1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EUZ.DE Yearly Revenue VS EstimatesEUZ.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EUZ.DE Yearly EPS VS EstimatesEUZ.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.72, which indicates a rather expensive current valuation of EUZ.
  • Compared to the rest of the industry, the Price/Earnings ratio of EUZ indicates a somewhat cheap valuation: EUZ is cheaper than 64.62% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.10. EUZ is around the same levels.
  • The Price/Forward Earnings ratio is 18.45, which indicates a rather expensive current valuation of EUZ.
  • EUZ's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. EUZ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.72
Fwd PE 18.45
EUZ.DE Price Earnings VS Forward Price EarningsEUZ.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 76.92% of the companies in the same industry are more expensive than EUZ, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EUZ indicates a somewhat cheap valuation: EUZ is cheaper than 73.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.13
EV/EBITDA 10.57
EUZ.DE Per share dataEUZ.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • EUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EUZ has a very decent profitability rating, which may justify a higher PE ratio.
  • EUZ's earnings are expected to grow with 16.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)2.74
EPS Next 2Y16.15%
EPS Next 3Y16.41%

3

5. Dividend

5.1 Amount

  • EUZ has a Yearly Dividend Yield of 1.10%.
  • EUZ's Dividend Yield is a higher than the industry average which is at 1.14.
  • EUZ's Dividend Yield is slightly below the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

  • The dividend of EUZ decreases each year by -43.97%.
Dividend Growth(5Y)-43.97%
Div Incr Years1
Div Non Decr Years3
EUZ.DE Yearly Dividends per shareEUZ.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • EUZ pays out 26.23% of its income as dividend. This is a sustainable payout ratio.
DP26.23%
EPS Next 2Y16.15%
EPS Next 3Y16.41%
EUZ.DE Yearly Income VS Free CF VS DividendEUZ.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EUZ.DE Dividend Payout.EUZ.DE Dividend Payout, showing the Payout Ratio.EUZ.DE Dividend Payout.PayoutRetained Earnings

ECKERT & ZIEGLER SE

FRA:EUZ (2/27/2026, 7:00:00 PM)

15.42

+0.25 (+1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-26
Inst Owners30.9%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap979.48M
Revenue(TTM)304.47M
Net Income(TTM)39.75M
Analysts80
Price Target22.06 (43.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly Dividend0.02
Dividend Growth(5Y)-43.97%
DP26.23%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)17.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 23.72
Fwd PE 18.45
P/S 3.22
P/FCF 22.13
P/OCF 14.73
P/B 4.23
P/tB 5.26
EV/EBITDA 10.57
EPS(TTM)0.65
EY4.22%
EPS(NY)0.84
Fwd EY5.42%
FCF(TTM)0.7
FCFY4.52%
OCF(TTM)1.05
OCFY6.79%
SpS4.79
BVpS3.65
TBVpS2.93
PEG (NY)0.45
PEG (5Y)2.74
Graham Number7.3
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 17.17%
ROCE 17.57%
ROIC 12.48%
ROICexc 18.59%
ROICexgc 22.77%
OM 21.27%
PM (TTM) 13.06%
GM 47.25%
FCFM 14.54%
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexgc growth 3Y11.22%
ROICexgc growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.05
Debt/EBITDA 0.43
Cap/Depr 106.5%
Cap/Sales 7.3%
Interest Coverage 85.33
Cash Conversion 77.65%
Profit Quality 111.36%
Current Ratio 2.93
Quick Ratio 2.37
Altman-Z 4.7
F-Score7
WACC7.12%
ROIC/WACC1.75
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)43.67%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%68.5%
EPS Next Y52.31%
EPS Next 2Y16.15%
EPS Next 3Y16.41%
EPS Next 5YN/A
Revenue 1Y (TTM)9.64%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%7.42%
Revenue Next Year7.52%
Revenue Next 2Y7.63%
Revenue Next 3Y8.1%
Revenue Next 5YN/A
EBIT growth 1Y7.47%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year46.04%
EBIT Next 3Y20.27%
EBIT Next 5Y16.43%
FCF growth 1Y300.82%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y52.85%
OCF growth 3Y25.28%
OCF growth 5Y10.49%

ECKERT & ZIEGLER SE / EUZ.DE FAQ

What is the fundamental rating for EUZ stock?

ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE.


Can you provide the valuation status for ECKERT & ZIEGLER SE?

ChartMill assigns a valuation rating of 5 / 10 to ECKERT & ZIEGLER SE (EUZ.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EUZ stock?

The Price/Earnings (PE) ratio for ECKERT & ZIEGLER SE (EUZ.DE) is 23.72 and the Price/Book (PB) ratio is 4.23.


Can you provide the dividend sustainability for EUZ stock?

The dividend rating of ECKERT & ZIEGLER SE (EUZ.DE) is 3 / 10 and the dividend payout ratio is 26.23%.